Looking at blood markers and a gene to explain thinking problems after brain radiation
Original title: Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is listed, so this is still research and not care your own doctor can give.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study looks at why brain radiation can make thinking harder.
Who this trial is for. This study is for people with a brain tumor that started in the brain or spread there. It checks markers in the blood and a gene called APOE in people who get brain radiation.
Where it stands. The study has not reported results. It is measuring blood markers and the APOE gene, then comparing them with how well people think. That answer is not in yet.
What this means, and what it doesn't
What it could mean: Doctors already know brain radiation can affect thinking. They do not know why it happens. This study may help explain the reason. If this sounds like your situation, you can ask your care team about it.
What it doesn't mean: This does not mean a new treatment is here. A trial is a test, not proven care. Being in one does not promise it will help you. It is not a promise of a cure.
Source: ClinicalTrials.gov, August 18, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.